ClinicalTrials.gg
Not yet recruitingNCT07814911Updated Sep 11, 2026

Acceptance and Commitment Therapy for Parenting Children With Cerebral Palsy

An interventional study of ACT intervention and Usual/standard control in Psychological Outcomes and Quality of Life, sponsored by The Hong Kong Polytechnic University. Not yet recruiting. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-11.

Primary conditionAnxiety Disorders(the registry's first term)UnverifiedIs this wrong?The registry often attaches Anxiety Disorders to studies about something else, and this study's title and listed conditions do not name it. No better condition is named, so the registry's term is kept.

Sponsored by The Hong Kong Polytechnic University · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
76
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this randomized controlled trial is to evaluate whether a group-based acceptance and commitment therapy (ACT) can improve the psychological outcomes and quality of life (QOL) of children with cerebral palsy. The main questions it aims to answer are:

  • Does a group-based ACT improve the psychological flexibility of the participants?
  • Does a group-based ACT improve the psychological distress, including depression, anxiety, and stress, of the participants?
  • Does a group-based ACT improve the QOL of the participants?

Researchers will compare a group-based ACT to usual/standard care to determine whether ACT improves participants' psychological outcomes and QOL.

Participants will:

  • Receive eight weekly, face-to-face, group-based ACT sessions, each lasting approximately 90 minutes.
  • Receive home-based practices following each session.
  • Receive a weekly phone call assessment to address any study-related concerns and provide reminders for the next appointment or assessment day.
  • Complete the questionnaires at three times: baseline (before intervention), post-intervention (at 8 weeks), and follow-up (6 weeks post-intervention).
02

Conditions studied

  • Psychological Outcomes
  • Quality of Life

Browse trials for

Keywords

  • Acceptance and Commitment Therapy
  • Psychological outcome
  • Anxiety
  • Depression
  • Stress
  • Psychological flexibility
  • Quality of life
  • Child
  • Parent
  • Cerebral palsy
03

In context

Anxiety Disorders Unverified

7,207 studies on the registry are indexed under Anxiety Disorders; 1,682 are open to participants now.

This study's planned enrollment of 76 is close to the median of 80 across 6,062 interventional studies indexed under Anxiety Disorders.

Browse Anxiety Disorders studies →

Lead sponsor

The Hong Kong Polytechnic University is the lead sponsor of 681 studies on the registry; 259 are open to participants now.

Compared within Anxiety Disorders, the registry's first condition term, which may not be this study's main condition. Counted across the registry records on this site, refreshed daily. How we classify →

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Parents of children under 18 years with any type and severity of cerebral palsy
  • Able to communicate in Amharic, and
  • Able to provide written consent for participation

Exclusion criteria

Exclusion Criteria:

  • Participants who have known psychological or psychiatric problems, and
  • Participants who are currently participating or have participated in another similar or related study within six months
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
76 participants (estimated)

Study arms

  • Experimental
    ACT intervention

    Behavioral: ACT intervention

  • Other
    Usual/standard treatment

    Other: Usual/standard control

Interventions

  • BehavioralACT intervention

    Participants in the intervention group will receive an ACT that consists of eight sessions. Th introductions include an introduction, cognitive defusion, acceptance, being present, values, committed action, and noticing self/self-as context, and a summary session. An ACT-trained researcher will deliver weekly, face-to-face, group-based sessions, each lasting approximately 90 minutes, though durations may vary to accommodate group variations. Each group will consist of five to seven participants. The interventions will be delivered via various strategies, including psychoeducation, discussion, mindfulness exercises, and metaphors supplemented with with home practices. A research assistant will conduct a weekly phone call assessment to address any study-related concerns and provide reminders for the next appointment or assessment day.

  • OtherUsual/standard control

    Participants in the control group will receive the usual or standard care provided by the respective center. To enhance participant retention in the study, a weekly phone call will be conducted by a research assistant, during which participants will be asked whether they have any concerns about the study and reminded of the next appointment or assessment day.

06

What researchers measure

Primary outcomes

  1. Level of psychological flexibility

    The psychological flexibility will be assessed using the 7-item Acceptance and Action Questionnaire-II (AAQ-II). Each item in the AAQ-II is scored on a scale of seven from 1(never true) to 7(always true). The total score is obtained by summing the scores of all items, and the higher the total score indicates greater psychological inflexibility.

    Time frame: Baseline (before intervention), post-intervention (at 8 weeks), and follow-up (6 weeks post-intervention).

  2. Level of psychological distress

    The psychological distress outcomes including, anxiety, depression, and stress will be assessed using the self-report 21-item anxiety, depression, and stress scale (DASS-21). Each of the subscales comprises 7 items and is scored on a four-point Likert scale ranging from 0(didn't apply at all to me) to 3(applied to me very much or most of the time), and the score is calculated by summing up the items in each subscale, and the final core is obtained by multiplying the core by two to make it comparable with the full scale (DASS-42). The higher the core indicates high distress symptoms.

    Time frame: Baseline (before intervention), post-intervention (at 8 weeks), and follow-up (6 weeks post-intervention).

Secondary outcomes

  1. Level of quality of life

    The quality of life will be evaluated by using the World Health Organization Quality of Life-BREF (WHOQOL-BREF). It comprises four domains: physical health, psychological, social relationships, and environment. Each item is scored on a five-point scale from 1 to 5, with varying response options across the domains, and some items need to be reversely scored. There are two items examined separately and will not be included in the score calculation. Domain scores are calculated by summing up the mean of all items in each domain and multiplying by four, and then the total score is transformed to a 0-100 scale to make the domains comparable. A higher the score indicates a higher QOL.

    Time frame: Baseline (before intervention), post-intervention (at 8 weeks), and follow-up (6 weeks post-intervention).

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Oct 2026; primary completion for Jan 2027, 3 months later.

Of 3,841 non-industry interventional studies with no phase under Anxiety Disorders, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 28. This study's planned 3 months is below that.

Counting every sponsor, half of 3,943 studies reached it within 12 months; a quarter within 5 and three quarters within 28.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 6, 2026
First posted
Sep 11, 2026
StartEst.
Oct 1, 2026
Primary completionEst.
Jan 31, 2027
CompletionEst.
Jan 31, 2027
Last update
Sep 11, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 11, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07814911
Responsible party
Kenneth N. K. Fong (Professor, The Hong Kong Polytechnic University) — Principal investigator
First posted
Sep 11, 2026
Start date
Oct 1, 2026 (estimated)
Primary completion
Jan 31, 2027 (estimated)
Completion
Jan 31, 2027 (estimated)
Last update
Sep 11, 2026

Study contacts

Kenneth N.K Fong, PhD
Contact
rsnkfong@polyu.edu.hk
+852 2766 6716
Tenaw Gualu Melesse, PhD
Contact
tgmeles@polyu.edu.hk
+852 5530 4750

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion